i am going to take a crack at this one......
now that we
i am going to take a crack at this one......
now that we are close to a breakout....me thinks you should just wait till the 16 th or so to feel the "cushion of positive revenue"......you have waited so long......don't sell/buy on emotions .....
yesterday the stock market's DOW/Nasdaq lost a gazillion dollars when they dropped over 500/150 points, is that the end of the story, noway....the dow/nasdaq will come back and reach new highs no matter what yesterday's china trade war jitters emotions were all about.....timing in the stock market is everything.....sell high buy low....use this mantra all the time.....when someone sells, someone else is buying, because they know it will turn around.....and they are buying at the low end.....
p.s. you will do what you want to do, please don't take what i said as financial advise, its just my take.....
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
In the hustle and bustle of manufacturing, EPG Modular Data Center has hit a landmark moment. They're not just slapping up another building—they're carving out a piece of future tech infrastructure with their fresh Malaysia FIZ Factory. Investing in Regional Strength When you pump US$120 million into a project, you're doing more than sinking cash into concrete—you're...
Continue Reading
Where Did It All Go Wrong for Tenax? They say the stock market is a rollercoaster, but Tenax Therapeutics, Inc. (NASDAQ: TENX) seems to have taken that expression way too literally. Imagine watching your investments tumble by nearly 90% in a single day. On August 10, 2026, that was the grim reality for Tenax's stockholders when the company's shares plummeted from over $13...
Continue Reading
Precision's Big Reveal at SITC 2026 When it comes to the shifting tides of oncology advancements, Precision Biologics is making some serious waves. They're not leaning back; they're diving right in with their latest showcase at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, 2026. CEO Dr. Philip M. Arlen announced compelling preclinical data for their...
Continue Reading
Mohegan Sun Aims for New Heights with Major Overhaul Tuck into this: Mohegan Sun Arena, that entertainment juggernaut nestled in Montville, is gearing up for a massive $30 million facelift. You're talking all-new seating, cutting-edge concessions, and premium hospitality that puts other venues to shame. Over Two Decades of Entertainment Excellence This isn’t just...
Continue Reading
CleanSpark's Strategy Gets the Spotlight Looks like CleanSpark's stepping up to the plate, folks. They're shouting from the rooftops about hitting the upcoming investor events, and it’s no small potatoes. The company’s lined up a string of high-profile conferences, showcasing their ambition to stay ahead in the energy and data center games. We're talking about the...
Continue Reading
When Revenue Goes South, Shares Follow Nothing like a Friday morning stock bloodbath to shake things up. MNTN, Inc. (NYSE:MNTN) had traders tossing back extra caffeine shots on November 5, 2026, when the company reported third-quarter revenues of $80.3 million. Let's just say that number didn't quite sit well with the folks who'd been banking on an $87.7 million...
Continue Reading
A Revenue Decrease in a Competitive Field Here's a story of a business navigating choppy waters while desperately trying to keep its head above. Under Armour (NYSE:UAA) has been battling through the second quarter of 2027 with a 7% revenue decline, landing at $1.2 billion. Hey, they're in the apparel game where every brand is trying to outpace the others. North American...
Continue Reading
Breaking New Ground with Founders Grove It’s not every day a community gets a new lease on life through bricks and mortar, but Milton Hershey School (MHS) just did exactly that. They've broken ground on Founders Grove, a piece of the Hershey West End development puzzle that reflects both history and future potential. This isn’t just another housing project—this...
Continue Reading
Taneytown Takes a Significant Leap Well, Taneytown's making noise, folks. Never thought this sleepy spot would pull off something so important, but here we are with Recovery 180 opening Taneytown’s first-ever residential Level 3.1 treatment facility. After four years of struggle, the largest venture in Carroll County is opening its doors to residents who desperately...
Continue Reading
The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...
Continue Reading
Top 5 Most Recently Viewed Articles
i-80 Gold Corp. (TSX: IAU) reported its fourth-quarter results on Feb 19, 2026, and the numbers are a mixed bag that traders should dissect carefully. Revenue from gold sales was $21.3 million for the quarter, which comes from selling 5,477 ounces at an average realized price of $3,887 per ounce. That’s a drop compared to Q4 '24 when they raked in $23.2 million from...
Continue Reading
Toyota Collaborates with Revel to Improve EV Charging Access Toyota Motor Corporation (NYSE: TM) has recently partnered with Revel, a leading electric vehicle (EV) charging network, to offer free fast charging services to Toyota and Lexus battery electric vehicle (BEV) customers in New York City. This initiative enhances the ownership experience and exemplifies Toyota's...
Continue Reading
Niu Technologies Enters the Powersports Arena Niu Technologies (NASDAQ: NIU), renowned for its electric two-wheeled vehicles, is set to make a significant impact on the powersports market at the upcoming AIMExpo 2025 in Las Vegas. This major event, taking place from February 5-7, will showcase Niu's innovative approach to mobility and potential growth opportunities....
Continue Reading
Takeda's Innovative Advancement for TAKHZYRO® in HAE Treatment Takeda, a leader in biopharmaceutical innovation, has successfully secured approval for an additional administration method for TAKHZYRO® (lanadelumab), specifically designed for patients aged 12 years and older suffering from Hereditary Angioedema (HAE). The European Medicines Agency (EMA) has greenlit a...
Continue Reading
Empowering Young Women to Shape Their Futures Recently, over 50 young women activists gathered to highlight the pressing need for world leaders to prioritize the rights of girls and young women at major global summits. This movement, called "What Girls Want," represents a united call for recognition and meaningful change from those in positions of power. Putting Girls at...
Continue Reading